You have read all your free articles, to continue reading subscribe to read the rest of this content.
Genmab A/S announced it has reached a milestone in its DuoBody technology platform collaboration with Janssen Biotech, Inc., triggering a $3 million payment. The milestone payment is for pre-clinical progress with a DuoBody product candidate targeting cancer. “This milestone marks further proAlready a subscriber Login You have read all your…
Our latest issue, No 03 2021, is out – sign up for a subscription today and stay updated on the Nordic life science industry's latest progress and challenges. The Nordic life science industry has not only survived, but managed to grow and develop during the pandemic. Read more about how…
BioArctic has announced the initiation of a research collaboration with Eisai aimed at further studying the profile of the investigational drug candidate BAN2401. The research collaboration with Eisai is in addition to the existing development and commercialization agreement for BAN2401. This newAlready a subscriber Login You have read all your…
Stockholm-based BioLamina recently signed a new R&D agreement with Roche to develop novel cell culture systems. The systems will be aimed at various applications, including stem cell research. BioLamina’s and Roche’s collaboration will focus on assessing laminin-based in-vitro cell culturAlready a subscriber Login You have read all your free articles,…
